Vagus Nerve Stimulation for Fibromyalgia
(R61VNS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether stimulating the vagus nerve through the skin can relieve pain and other symptoms in people with fibromyalgia. Fibromyalgia is a chronic condition causing widespread pain and fatigue, and scientists are still investigating its causes. Participants will receive either the actual nerve stimulation treatment, known as Transcutaneous Vagus Nerve Stimulation (tVNS), or a sham version to compare effects. Ideal candidates for this trial have been diagnosed with fibromyalgia for at least three months and regularly experience significant pain. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could lead to new treatment options for fibromyalgia.
What prior data suggests that transcutaneous vagus nerve stimulation (tVNS) is safe for fibromyalgia patients?
Research has shown that using a device on the skin to stimulate the vagus nerve, known as transcutaneous vagus nerve stimulation (tVNS), is generally safe for people with fibromyalgia. Studies have found that tVNS, a noninvasive treatment, can help reduce pain in those with fibromyalgia. These studies reported no serious side effects. Some minor side effects, such as difficulty swallowing or temporary changes in voice, were noted but did not last long. Overall, tVNS appears to be a promising and safe option for managing pain in fibromyalgia.12345
Why are researchers excited about this trial?
Unlike the standard treatments for fibromyalgia, which typically involve medications like antidepressants, anticonvulsants, and pain relievers, Transcutaneous Vagus Nerve Stimulation (tVNS) offers a non-drug approach. Researchers are excited about tVNS because it uses electrical impulses to stimulate the vagus nerve through the skin, potentially reducing pain and improving mood without the side effects associated with medication. This technique targets the nervous system directly, which may provide relief more efficiently and with fewer side effects than conventional drug therapies. Additionally, its non-invasive nature means it could be a more accessible and safer option for patients.
What evidence suggests that transcutaneous vagus nerve stimulation might be an effective treatment for fibromyalgia?
Research has shown that transcutaneous vagus nerve stimulation (tVNS), a treatment participants in this trial may receive, might help people with fibromyalgia by reducing pain and improving quality of life. Studies have found that tVNS can significantly decrease pain levels in patients and enhance overall well-being and muscle strength. This treatment likely works by calming the nervous system and reducing inflammation, both of which are issues in fibromyalgia. Overall, tVNS appears to be a promising, safe, and effective way to manage fibromyalgia symptoms.678910
Who Is on the Research Team?
Lucy Chen, M.D.
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for adults diagnosed with fibromyalgia who are seeking new ways to manage their pain and symptoms. Specific inclusion or exclusion criteria were not listed, but generally participants should be able to use a non-invasive device and follow study instructions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either active tVNS treatment or a sham treatment for 6 weeks, with sessions twice a day for 30 minutes each
Follow-up
Participants complete a follow-up phone call to assess pain levels and any side effects
What Are the Treatments Tested in This Trial?
Interventions
- Transcutaneous Vagus Nerve Stimulation (tVNS)
Trial Overview
The study tests whether using a device called VagaCalm, which stimulates the vagus nerve through the skin (transcutaneous vagus nerve stimulation), can help reduce pain and other symptoms in people with fibromyalgia.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Receive tVNS 30 minutes per session, twice/day for 6 weeks and maintain regular medication treatment without change. Post study follow up will occur 2 weeks after completing the 6-week treatment.
Receive sham point stimulation 30 minutes per session, twice/day for 6 weeks and maintain regular medication treatment without change. Post study follow up will occur 2 weeks after completing the 6-week treatment.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
Citations
Vagus Nerve Stimulation(VNS) As Treatment For ...
The investigators propose to examine the hypothesis that vagus nerve stimulation could improve pain and related comorbid symptoms for FM patients.
2.
centerwatch.com
centerwatch.com/clinical-trials/listings/NCT06009159/vagus-nerve-stimulationvns-as-treatment-for-fibromyalgia-patientsVagus Nerve Stimulation(VNS) As Treatment For ...
The investigators propose to examine the hypothesis that vagus nerve stimulation could improve pain and related comorbid symptoms for FM ...
Transcutaneous Auricular Vagal Nerve Stimulation Against ...
Fatigue and quality of life improved in all groups, but no differences were observed between them. taVNS appears safe and well accepted, but did not reduce ...
4.
vagustim.io
vagustim.io/blogs/news/vns-fibromyalgia-management?srsltid=AYCX9vIRIIO3XR4P54oOS9Wy4OnJIiCPVpCnCJsXdIk37J5frDbqQ7WvVagus Nerve Stimulation: A New Hope for Fibromyalgia ...
Both studies reported promising outcomes, with a significant reduction in pain intensity and an overall improvement in the patients' quality of life.
Effects of transcutaneous vagus nerve stimulation on chronic ...
All six trials found that TVNs were beneficial in lowering pain intensity, boosting quality of life, back muscular endurance, and functional ...
Vagus Nerve Stimulation(VNS) As Treatment For ...
The primary outcome measure will be pain intensity. The secondary outcome measures will be fatigue, sleep, and other health-related quality of life measure. a ...
Vagus Nerve Stimulation in Fibromyalgia - ClinicalTrials.Veeva
Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients.
The Effect of Vagus Nerve Stimulation on Pain Severity Scores ...
Across included studies, the pooled effect size demonstrated a significant mean improvement in pain severity from pre-treatment to post-treatment of 2.32 points ...
9.
centerwatch.com
centerwatch.com/clinical-trials/listings/NCT06237595/vagus-nerve-stimulation-in-fibromyalgiaVagus Nerve Stimulation in Fibromyalgia
Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients.
10.
scholars.mssm.edu
scholars.mssm.edu/en/publications/safety-and-efficacy-of-vagus-nerve-stimulation-in-fibromyalgia-a--2/Safety and Efficacy of Vagus Nerve Stimulation in Fibromyalgia
Preliminary outcome measures suggested that VNS may be a useful adjunct treatment for FM patients resistant to conventional therapeutic management, but further ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.